SYRE Operating Cash Flow (Statement)
Spyre Therapeutics Inc · Operating Cash Flow (Statement)
SYRE Operating Cash Flow (Statement)
Latest reported-$69.88Mperiod ending
SYRE Quarterly Cash from Operations (-$1.34M → -$69.88M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
SYRE operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -69,877,000 | |
| -57,372,000 | |
| -44,578,000 | |
| -37,117,000 | |
| -46,563,000 | |
| -40,994,000 | |
| -37,199,000 | |
| -29,421,000 | |
| -62,248,000 | |
| -28,542,000 | |
| -31,036,000 | |
| -34,597,000 | |
| -16,643,000 | |
| -17,634,000 | |
| -18,140,000 | |
| -15,068,000 | |
| -20,673,000 | |
| -26,263,000 | |
| -19,268,000 | |
| -17,000,000 | |
| 2,082,000 | |
| -19,530,000 | |
| -17,132,000 | |
| -17,536,000 | |
| -19,413,000 | |
| -21,694,000 | |
| -16,294,000 | |
| -17,208,000 | |
| -16,383,000 | |
| -15,807,000 | |
| -7,200,000 | |
| -8,502,000 | |
| -9,044,000 | |
| -7,447,000 | |
| -5,873,000 | |
| -7,368,000 | |
| -5,942,000 | |
| -5,432,000 | |
| -4,355,000 | |
| -5,865,000 | |
| -4,632,000 | |
| -3,988,000 | |
| -833,000 | |
| -3,811,000 | |
| -3,855,000 | |
| -2,483,000 | |
| -2,975,000 | |
| -1,802,000 | |
| -1,217,000 | |
| -1,341,000 |